Beste apotheek van Nederland

Shabsigh R, Rajfer J, Aversa A et al. The evolving role of
testosterone in the treatment of erectile dysfunction. Int J Clin
Pract 2006;60(9):1087-1092.
Sharlip I. Diagnosis and treatment of premature ejaculation: The
physician's perspective. Br J Sex Med 2005;2(SUPPL. 2):103­
109.
Sharlip I D. Does natural erectile function improve following
intracavernous injections of vasoactive drugs?. [Review] [12
refs]. Int J Impot Res 1997;9(4):193-196.
Sharlip I D. Evaluation and nonsurgical management of erectile
dysfunction. Urol Clin North Am 1998;25(4):647-659.
Shinlapawittayatorn K, Chattipakorn S, Chattipakorn N. Effect
of sildenafil citrate on the cardiovascular system. Brazilian
Journal of Medical & Biological Research 2005;38(9):1303­
1311.
Simonsen U. Interactions between drugs for erectile dysfunction
and drugs for cardiovascular disease. [Review] [121 refs]. Int J
Impot Res 2002;14(3):178-188.
Singh J C, Devasia A, Gnanaraj L et al. Erectile dysfunction.
[Review] [21 refs]. Natl Med J India 2005;18(3):139-143.
Smith David M, Levitte Susan S. Association of fluoxetine and
return of sexual potency in three elderly men. Hillside J Clin
Psychiatry 1993;54(8):317-319.
Snow K J. Erectile dysfunction: A review and update. Hosp
Formul 2004;39(5):261-268.
Solomon H, DeBusk R F, Jackson G. Erectile dysfunction: The
need to be evaluated, the right to be treated. Am Heart J
2005;150(4):620-626.
Sommer F, Engelmann U. Future options for combination
therapy in the management of erectile dysfunction in older men.
Drugs Aging 2004;21(9):555-564.
Sperling H, Lummen G, Schneider T et al. [New treatment
options for erectile dysfunction. Pharmacologic and
nonpharmacologic options]. Herz 2003;28(4):314-324.
Stahl Stephen M. How psychiatrists can build new therapies for
impotence. Hillside J Clin Psychiatry 1998;59(2):47-48.
Steers W D. Viability and safety of combination drug therapies
for erectile dysfunction. [Review] [20 refs]. Br J Urol
2003;170(2:Pt 2):t-3.
Steers W D, Rosen R, Andersson K-E et al. Viability and safety
of combination drug therapies for erectile dysfunction. Br J Urol
2003;170(2 II):S20-S23.
Stenager Egon, Stenager Elsebeth, Nylev Jensen et al. Sexual
problems in multiple sclerosis. Int J Adolesc Med Health
1994;7(2):95-105.
Stimmel G L, Gutierrez M A. Pharmacologic
treatment strategies for sexual dysfunction in patients
with epilepsy and depression. CNS Spectr
2006;11(SUPPL. 9):31-37.
Sui Z. Phosphodiesterase-5 inhibitors for male erectile
dysfunction. Expert Opinion on Therapeutic Patents
2003;13(9):1373-1388.
Susman E. American Urological Association - 97th
Annual Meeting: Progress in sexual dysfunction: 25­
30 May 2002, Orlando, FL, USA. IDrugs
2002;5(7):666-669.
Swerdloff R S, Wang C. Androgens and the ageing
male. Best Practice & Research Clinical
Endocrinology & Metabolism 2004;18(3):349-362.
Telang D J, Farah R N. Management of impotence
after treatment of carcinoma of the prostate. [Review]
[16 refs]. Henry Ford Hosp Med J 1992;40(1-2):111­
113.
Teloken C. Management of erectile dysfunction
secondary to treatment for localized prostate cancer.
[Review] [42 refs]. Cancer Control 2001;8(6):540­
545.
Temel Y, Hafizi S, Beuls E et al. The supraspinal
network in the control of erection. Expert Opin Ther
Targets 2005;9(5):941-954.
Tenover J S. Prevalence and management of mild
hypogonadism: Introduction. Int J Impot Res
2003;15(SUPPL. 4):S1-S2.
Thachil A, Bhugra D. Literature update: A critical
review. Sexual & Relationship Therapy
2005;20(4):457-464.
Thomas J A. Pharmacological aspects of erectile
dysfunction. Jpn J Pharmacol 2002;89(2):101-112.
Tilton Margaret C. Diabetes and amputation. Sipski,
Marca L (Ed); Alexander, Craig J (Ed)
1997;(1997):651
Toda N, Ayajiki K, Okamura T. Nitric oxide and
penile erectile function. Pharmacol Ther
2005;106(2):233-266.
Toone Brian K. Sexual dysfunction. Keshavan,
Matcheri S (Ed); Kennedy, John S (Ed)
1992;(1992):339
Tran D, Howes L G. Cardiovascular safety of
sildenafil. [Review] [38 refs]. Drug Saf
2003;26(7):453-460.
D-49